News on Xenobiotics from BioPortfolio.com http://www.BioPortfolio.com Consolidated Xenobiotics news from BioPortfolio.com Wed, 10 Feb 2010 08:35:47 GMT en Pharmacokinetics: Research conducted at Avigen, Inc. has provided new information about pharmacokineticshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033259&HITNO=0&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Xenobiotics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033259&THISHREF=http://c.moreover.com/click/here.pl%3fz2535088698%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033259&HITNO=0&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Xenobiotics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033259&THISHREF=http://c.moreover.com/click/here.pl%3fz2535088698%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Metabolism: Findings in metabolism reported from Genentech, Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027476&HITNO=1&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Xenobiotics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027476&THISHREF=http://c.moreover.com/click/here.pl%3fz2532208517%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027476&HITNO=1&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Xenobiotics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027476&THISHREF=http://c.moreover.com/click/here.pl%3fz2532208517%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Pharmaceuticals: Reports from University of Tromso, Institute of Medical Biology describe recent advances in pharmaceuticalshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980679&HITNO=2&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Xenobiotics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980679&THISHREF=http://c.moreover.com/click/here.pl%3fz2506515796%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3980679&HITNO=2&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Xenobiotics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3980679&THISHREF=http://c.moreover.com/click/here.pl%3fz2506515796%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Medpace Medical Director, Jim Wei, MD, PhD To Present At The Outsourcing Clinical Trials Conference, January 27-28, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962839&HITNO=3&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Xenobiotics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962839&THISHREF=http://c.moreover.com/click/here.pl%3fz2497507649%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3962839&HITNO=3&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Xenobiotics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3962839&THISHREF=http://c.moreover.com/click/here.pl%3fz2497507649%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Medpace Medical Director, Jim Wei, MD, PhD to Present at the Outsourcing Clinical Trials Conference, January 2http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959486&HITNO=4&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Xenobiotics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959486&THISHREF=http://c.moreover.com/click/here.pl%3fz2495794545%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959486&HITNO=4&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Xenobiotics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959486&THISHREF=http://c.moreover.com/click/here.pl%3fz2495794545%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioSpace: Inflammation Therapy: Scientists at Michigan State University publish research in inflammation therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3922094&HITNO=5&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Xenobiotics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3922094&THISHREF=http://c.moreover.com/click/here.pl%3fz2475672105%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3922094&HITNO=5&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Xenobiotics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3922094&THISHREF=http://c.moreover.com/click/here.pl%3fz2475672105%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Tacrolimus Therapy: New tacrolimus therapy study findings recently were reported by researchers at Mallinckrodt, Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3864808&HITNO=6&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Xenobiotics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3864808&THISHREF=http://c.moreover.com/click/here.pl%3fz2446118936%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3864808&HITNO=6&MSIZE=7&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Xenobiotics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3864808&THISHREF=http://c.moreover.com/click/here.pl%3fz2446118936%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: